PharmaEssentia

PharmaEssentia conducts clinical research in hematology and oncology, supported by study sites, investigators, patients, caregivers, and clinicians.

Providing scientific and medical information to healthcare professionals

Advancing the treatment of hematologic diseases

PharmaEssentia shares patient stories to inform, educate, and advocate for those living with myeloproliferative neoplasms (MPNs).

Chronic Hepatitis B/ Chronic Hepatitis D

Potential expansion of the BESREMi (ropeginterferon alfa-2b-njft) product label to include adult patients with essential thrombocythemia (ET)

The page describes PharmaEssentia’s goal of developing therapies for myeloproliferative neoplasms and other hematological diseases and cancers.

New regimen for ropeginterferon alfa2b-njft enables patients to reach target dose faster, supporting positive clinical outcomes and enabling faster achievement of maintenance dose

US$46 million investment to establish wholly owned Puerto Rico subsidiary supporting U.S. manufacturing, supply security, and long-term growth of BESREMi (ropeginterferon alfa-2b)

PharmaEssentia is a growing biopharmaceutical company seeking new talent to contribute to its work.

Plant Director of Taichung Manufacturing Plant

Leading the way to new therapies for MPNs and other hematological diseases and cancers

PharmaEssentia Corporation (TWSE : 6446) is a fully integrated global biopharmaceutical company

PharmaEssentia Corporation (TWSE : 6446) is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to stakeholders

PharmaEssentia was founded in 2003 to combine biology and synthetic organic chemistry for new therapies. The company began in Taipei’s Nangang Software Park with an initial investment from its founder and a small team of scientists.

PharmaEssentia USA is a fully integrated biopharmaceutical company bringing new therapies to patients with MPNs and other hematologic cancers.

PharmaEssentia is a global biopharmaceutical company focused on therapies for blood disorders and serious diseases.

ファーマエッセンシアジャパン株式会社の公式ホームページ provides medical, business, and recruitment information for healthcare professionals, patients, and families.

PharmaEssentia Corp. outlines how it collects and uses personal data through user interactions with its website.